Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Cancer, Clearly
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Quick Quiz
For Authors
We are not currently accepting manuscripts.
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Cancer, Clearly
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Quick Quiz
For Authors
We are not currently accepting manuscripts.
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Web Exclusives
HOPA Corner
Executive Summary—2026 HOPA Scope of the Oncology Pharmacist Provider
Kelly M. Brunk, PharmD, MBA, BCOP; Jill Bates, PharmD, MS, BCOP, DipACLM, FASHP; Eve M. Segal, PharmD, BCOP; Sara L. Fleszar, PharmD, BCOP; Julie Kennerly-Shah, PharmD, MS, MHA, BCPS; and Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP, FCPA, FCCP
Read More
FDA Updates
,
Pancreatic Cancer
FDA Approval of Daraxonrasib: A New Era for Pancreatic Cancer Treatment
Read More
HOPA Corner
GLP-1s in Oncology: Exploring Risks and Potential Benefits
Colleen McCabe, PharmD, BCOP; Lindsay Mundy, PharmD, BCOP
Read More
HOPA Corner
Updates in Small Cell Lung Cancer
Katie O’Reilly, PharmD, BCOP
Read More
HOPA Corner
Mind Over Metastases: Navigating Central Nervous System Involvement in Solid Tumors
Kelly Fritz, PharmD, BCOP; Sara deHoll, PharmD, BCOP
Read More
HOPA Corner
,
Immunotherapy
Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy
Read More
HOPA Corner
DLL3-Targeting BiTE Therapy in SCLC: A Pharmacist’s Guide to Evidence and Integration
Read More
HOPA Corner
Checkpoint Inhibitors: Changing Colorectal Cancer Treatment
Read More
HOPA Corner
505(b)(2) Drugs: New Chaos for Infusion Centers
Read More
HOPA Corner
,
Disparities in Oncology Care
The Crossroad of Social Determinants of Health and Inequalities in Hematologic Malignancies
By Cara Guglielmon
Read More
1
2
3
4
Page 1 of 43
Results 1 - 10 of 430
